Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis
Key facts
- Where
- Valencia, SpanyolországSee the site
- Phase
- 4. fázis
Where in Spanyolország
- Hospital Universitario Dr. Peset AleixandreValencia, SpanyolországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
- Trial code
- EU 2024-519356-87-00
- Record updated
- 2026. június 17.
- Original description
To study the clinical response to furosemide administered intraperitoneally compared to orally on the hydration status of stable patients in a PD unit.Read full original descriptionShow less
To study the clinical response to furosemide administered intraperitoneally compared to orally on the hydration status of stable patients in a PD unit.
Inclusion: Patients on treatment with a daily dose equal to or higher than 120 mg of stable oral furosemide during previous fifteen days ; Patients over 18 years of age; Clinically stable patients in PD technique; Patients with a normofunctioning PD catheter; Patients with residual diuresis greater than 500ml per day; Patients who have undergone a peritoneal equilibrium test in the previous three months; Patients who wish to participate and who sign the informed consent form.
Exclusion: Inability of the patient or caregiver to administer intraperitoneal therapy at home; Allergy to furosemide; Need to modify the rest of the oral diuretic treatment at the time of inclusion in the study and during follow-up.